NCT00028275View on ClinicalTrials.gov

Gamma Interferon Therapy for Chronic Hepatitis C

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2001

Study Completion Date

November 30, 2003

Conditions
Chronic Hepatitis C
Interventions
DRUG

Gamma Interferon 1b

Trial Locations (1)

20892

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00028275 - Gamma Interferon Therapy for Chronic Hepatitis C | Biotech Hunter | Biotech Hunter